Resultados de la búsqueda 2051-2060 of 4663 for Blood factor II
This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this combination ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...
The primary purpose of the phase II study is ... II). Additinoally, to evaluate the effectiveness ... blood samples) are predictors of treatment success.
... (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with ...
The objective of this study is to collect tumor specimens (tumor tissues, matched normal tissue when possible, and 50 mL of blood) that may inform cancer ...
NHS Blood and Transplant. https://www.nhsbt.nhs ... Kidney transplantation in adults: Risk factors for graft failure. ... 2 diabetes Dec. 06, 2024, 05:00 p.m. CDT ...
The purpose of this study is to develop a biorepository of blood samples from cancer patients participating in the Gemini (IRB 19-006717) protocol. These ...
Connect with others like you for support and answers to your questions in the Heart & Blood Health support group on Mayo Clinic Connect, a patient community.
Some people with Waldenstrom macroglobulinemia develop hyperviscosity syndrome. Hyperviscosity refers to the thickening of the blood that leads to slower flow ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?